Astrana Operating Income from 2010 to 2026

ASTH Stock

22.41 0.41 1.86%

Astrana Health's Operating Income is increasing with slightly volatile movements from year to year. Operating Income is estimated to finish at about 107.9 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Astrana Health generates from its operations. View All Fundamentals

Operating Income

First Reported

2001-09-30

Previous Quarter

20.3 M

Current Value

19.2 M

Quarterly Volatility

14.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 40 M, Other Operating Expenses of 2.3 B or Operating Income of 107.9 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0029 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.

Build AI portfolio with Astrana Stock

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Latest Astrana Health's Operating Income Growth Pattern

Below is the plot of the Operating Income of Astrana Health over the last few years. Operating Income is the amount of profit realized from Astrana Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Astrana Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Astrana Health's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Astrana Operating Income Regression Statistics

	Arithmetic Mean	43,008,492
	Coefficient Of Variation	112.70
	Mean Deviation	44,496,613
	Median	32,420,000
	Standard Deviation	48,468,666
	Sample Variance	2349.2T
	Range	118.4M
	R-Value	0.85
	Mean Square Error	684.4T
	R-Squared	0.73
	Significance	0.000014
	Slope	8,183,126
	Total Sum of Squares	37587.4T

Astrana Operating Income History

	2026	107.9 M
	2025	102.8 M
	2024	89.3 M
	2023	84.6 M
	2022	104.3 M
	2021	98.2 M
	2020	6.1 M

Other Fundumenentals of Astrana Health

Non Operating Income Net Other

Astrana Health Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.66	0.94	0.72	0.97	0.99	0.52	0.81	0.93	0.93	0.22	0.96	1.0	0.18	0.89	0.97	0.3	0.93	0.93	0.35	0.77	0.89	0.9	0.9
Total Stockholder Equity	0.98		0.63	0.99	0.67	0.97	0.99	0.53	0.81	0.94	0.97	0.11	0.95	0.96	0.03	0.86	0.98	0.16	0.85	0.98	0.38	0.71	0.92	0.89	0.95
Net Debt	0.66	0.63		0.67	0.3	0.78	0.7	0.27	0.69	0.8	0.48	-0.01	0.83	0.65	0.25	0.68	0.51	0.13	0.52	0.6	0.48	0.27	0.65	0.55	0.59
Retained Earnings	0.94	0.99	0.67		0.6	0.96	0.96	0.53	0.8	0.95	0.94	0.0	0.95	0.92	-0.05	0.82	0.93	0.06	0.77	0.98	0.41	0.6	0.92	0.84	0.95
Accounts Payable	0.72	0.67	0.3	0.6		0.68	0.67	0.28	0.6	0.63	0.61	-0.04	0.6	0.76	0.0	0.49	0.69	0.02	0.82	0.61	0.25	0.65	0.53	0.48	0.55
Total Liab	0.97	0.97	0.78	0.96	0.68		0.99	0.49	0.84	0.98	0.9	0.08	0.99	0.97	0.1	0.86	0.92	0.18	0.86	0.93	0.42	0.67	0.9	0.85	0.9
Total Current Assets	0.99	0.99	0.7	0.96	0.67	0.99		0.52	0.82	0.95	0.93	0.19	0.98	0.98	0.17	0.9	0.97	0.26	0.89	0.95	0.37	0.73	0.91	0.91	0.92
Common Stock	0.52	0.53	0.27	0.53	0.28	0.49	0.52		0.39	0.44	0.53	0.11	0.49	0.51	0.12	0.52	0.55	0.1	0.46	0.53	0.29	0.21	0.6	0.59	0.58
Short Term Debt	0.81	0.81	0.69	0.8	0.6	0.84	0.82	0.39		0.76	0.74	0.08	0.84	0.8	0.23	0.82	0.79	0.16	0.72	0.8	0.77	0.55	0.79	0.73	0.75
Net Receivables	0.93	0.94	0.8	0.95	0.63	0.98	0.95	0.44	0.76		0.87	-0.01	0.96	0.93	-0.02	0.76	0.86	0.13	0.8	0.9	0.34	0.62	0.86	0.76	0.87
Net Tangible Assets	0.93	0.97	0.48	0.94	0.61	0.9	0.93	0.53	0.74	0.87		0.11	0.86	0.92	-0.07	0.79	0.96	0.21	0.81	0.96	0.32	0.74	0.87	0.85	0.91
Current Deferred Revenue	0.22	0.11	-0.01	0.0	-0.04	0.08	0.19	0.11	0.08	-0.01	0.11		0.13	0.21	0.71	0.37	0.24	0.72	0.32	0.0	-0.1	0.48	0.1	0.4	0.11
Long Term Debt	0.96	0.95	0.83	0.95	0.6	0.99	0.98	0.49	0.84	0.96	0.86	0.13		0.94	0.19	0.9	0.9	0.21	0.82	0.92	0.44	0.63	0.9	0.87	0.9
Good Will	1.0	0.96	0.65	0.92	0.76	0.97	0.98	0.51	0.8	0.93	0.92	0.21	0.94		0.18	0.86	0.96	0.32	0.95	0.91	0.35	0.78	0.86	0.87	0.87
Short Term Investments	0.18	0.03	0.25	-0.05	0.0	0.1	0.17	0.12	0.23	-0.02	-0.07	0.71	0.19	0.18		0.5	0.14	0.67	0.31	-0.03	0.16	0.19	0.09	0.39	0.01
Long Term Debt Total	0.89	0.86	0.68	0.82	0.49	0.86	0.9	0.52	0.82	0.76	0.79	0.37	0.9	0.86	0.5		0.88	0.37	0.79	0.84	0.45	0.62	0.84	0.95	0.84
Capital Surpluse	0.97	0.98	0.51	0.93	0.69	0.92	0.97	0.55	0.79	0.86	0.96	0.24	0.9	0.96	0.14	0.88		0.26	0.89	0.95	0.34	0.78	0.89	0.93	0.92
Deferred Long Term Liab	0.3	0.16	0.13	0.06	0.02	0.18	0.26	0.1	0.16	0.13	0.21	0.72	0.21	0.32	0.67	0.37	0.26		0.47	0.05	-0.09	0.49	0.08	0.37	0.03
Intangible Assets	0.93	0.85	0.52	0.77	0.82	0.86	0.89	0.46	0.72	0.8	0.81	0.32	0.82	0.95	0.31	0.79	0.89	0.47		0.76	0.28	0.82	0.73	0.79	0.72
Property Plant Equipment	0.93	0.98	0.6	0.98	0.61	0.93	0.95	0.53	0.8	0.9	0.96	0.0	0.92	0.91	-0.03	0.84	0.95	0.05	0.76		0.39	0.63	0.92	0.87	0.96
Short Long Term Debt	0.35	0.38	0.48	0.41	0.25	0.42	0.37	0.29	0.77	0.34	0.32	-0.1	0.44	0.35	0.16	0.45	0.34	-0.09	0.28	0.39		0.09	0.48	0.34	0.39
Long Term Investments	0.77	0.71	0.27	0.6	0.65	0.67	0.73	0.21	0.55	0.62	0.74	0.48	0.63	0.78	0.19	0.62	0.78	0.49	0.82	0.63	0.09		0.66	0.71	0.65
Net Invested Capital	0.89	0.92	0.65	0.92	0.53	0.9	0.91	0.6	0.79	0.86	0.87	0.1	0.9	0.86	0.09	0.84	0.89	0.08	0.73	0.92	0.48	0.66		0.9	0.97
Net Working Capital	0.9	0.89	0.55	0.84	0.48	0.85	0.91	0.59	0.73	0.76	0.85	0.4	0.87	0.87	0.39	0.95	0.93	0.37	0.79	0.87	0.34	0.71	0.9		0.9
Capital Stock	0.9	0.95	0.59	0.95	0.55	0.9	0.92	0.58	0.75	0.87	0.91	0.11	0.9	0.87	0.01	0.84	0.92	0.03	0.72	0.96	0.39	0.65	0.97	0.9

Click cells to compare fundamentals

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's Operating Income, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Operating Income	102.8 M	107.9 M
Non Operating Income Net Other	-11.2 M	-10.6 M

Currently Active Assets on Macroaxis

WD	Walker Dunlop
GM	General Motors
GM	General Motors
BAC	Bank of America
S	SentinelOne

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.98)

Earnings Share

0.19

Revenue Per Share

59.463

Quarterly Revenue Growth

0.997

Return On Assets

0.0288

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Astrana Operating Income from 2010 to 2026

Latest Astrana Health's Operating Income Growth Pattern

Astrana Operating Income Regression Statistics

Astrana Operating Income History

Other Fundumenentals of Astrana Health

Astrana Health Operating Income component correlations

About Astrana Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY